Bayer had four patents in ecommerce during Q2 2024. The patent filed by Bayer AG in Q2 2024 describes a method for authenticating and tracking a patient’s eligibility to purchase an over-the-counter drug online. The process involves redirecting the patient to a backend platform to assess eligibility, searching for any disqualifying information, administering a questionnaire, and completing or canceling the sale based on eligibility. GlobalData’s report on Bayer gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Bayer had no grants in ecommerce as a theme in Q2 2024.
Recent Patents
Application: Authenticating, establishing and tracking eligibility of a patient to purchase an over-the-counter drug (Patent ID: US20240177820A1)
The patent filed by Bayer AG describes a method and apparatus for authenticating, establishing, and tracking the eligibility of a patient to purchase an over-the-counter (OTC) drug from a retailer using a client device. The system involves redirecting the client device to a backend platform to authenticate the patient, assess eligibility through a questionnaire, and complete or cancel the online sale based on eligibility. The apparatus includes a memory, processor, and communication capabilities to interact with the retailer's server and store information about patient eligibility.
The method involves communicating with the retailer's server, authenticating the patient, determining eligibility through a questionnaire, and completing or canceling the online sale based on eligibility. Information indicating patient ineligibility is stored for future reference, and the system can interact with multiple retailers for subsequent sales. The process includes prompting the patient for unique information, administering a specific questionnaire, and storing survey data for future reference and confirmation. Overall, the patent outlines a comprehensive system for ensuring patient eligibility and authentication when purchasing OTC drugs online.
To know more about GlobalData’s detailed insights on Bayer, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
